Anti-idiotype antibodies reactive with shared idiotopes expresse

Details Anti-idiotype antibodies reactive with shared idiotopes expresse Anti-idiotype antibodies reactive with shared idiotopes expresse

1992-06-12

1993-07-13

Lacey, David L.

Drug, bio-affecting and body treating compositions

Lymphokine

5303872, 53038873, 5303888, 435 7021, 4351722, 43524027, 935104, 935107, A61K 39395, C07K 1528, C12N 520

Patent

active

052271595

ABSTRACT:
B-cell lymphomas express surface immunoglobulin (immunoglobulin) containing unique idiotypic (idiotype) determinants which may be exploited as tumor specific markers. The inventor has produced murine monoclonal antibodies (MAbs) reactive with the idiotype marker derived from 67 patients with low grade, follicular, small cleaved cell lymphoma. Out of 199 monoclonal antibodies, 47 (24%) were found to react with pooled normal human serum immunoglobulin in concentrations ranging from 0.6 .mu.g/ml to 160 .mu.g/ml. Of these 40 monoclonal antibodies, 90% cross-reacted with idiotype present in normal serum in levels <50 .mu.g/ml. Thirty-two of these anti-idiotypes were directed against a shared idiotope expressed on another patient's lymphoma cells. The frequency of shared idiotope expression defined by each antibody ranged from 0.26% to 3.9% of the B-cell lymphomas tested. A panel of five anti-idiotype antibodies reacted with 80% of AIDS associated lymphomas. Based on the reactivity with these monoclonal antibodies, tumors could be grouped into distinct families. In aggregate, these 32 monoclonal antibodies reacted with a total of 108 of 332 B cell lymphoma cases (32.5%), including 35 of 116 follicular, small cleaved cell lymphomas (30%). Many of these anti-shared idiotopes reacted with more than one histopathologic subtype of lymphoma. Anti-idiotypes have been used in B-cell lymphoma diagnosis and therapy. Moreover, applicant has discovered at least seven anti-shared idiotype antibodies that cross react with autoantibodies, e.g., 16.6 and RF. The development of a library of anti-idiotypes reactive with shared idiotopes should facilitate these clinical studies by obviating the need to develop a customized hybridoma for each patient.

REFERENCES:
patent: 4661586 (1987-04-01), Levy et al.
Miller et al., "Treatment of B-cell Lymphoma With Monoclonal Anti-Idiotype Antibody," N. Engl. J. Med. 306:517-522, Mar. 4, 1982.
Meeker et al., "A Clinical Trial of Anti-Idiotype Therapy for B-Cell Malignancy," Blood 65:1349-1363, Jun. 1985.
Miller et al., "Shared Idiotypes Expressed by Human B-cell Lymphomas," N Engl. J. Med. 321:851-857, Sep. 28, 1989.
Stevenson et al., "Antibodies to Shared Idiotypes as Agents for Analysis and Therapy for Human B cell Tumors," Blood 68:430-436, Aug., 1986.
Pasquali, J-L. A highly conserved determinant on human rheumatoid factor idiotypes defined by a mouse monoclonal antibody. 1983. Eur. J. Immunol. 13:197-201.
Carson, D. A., and Fong, S. A common idiotype on human rheumatoid factors identified by a hybridoma antibody. 1983. Molec. Immunol. 20: 1081-1087.
Perek, Y., et al. Immunotherapy of a murine B cell tumor with antibodies and F(ab').sub.2 fragments against idiotypic determinants of its cell surface IgM. 1983. J. Immunol. 131:1600-1603.
Thielemans, K., et al. Strategies for production of monoclonal anti-iodiotype antibodies against human B cell lymphomas. 1984. J. Immunol. 133:495-501.
Pennell, C. A., et al. Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: Etiological implications. Proc. Natl. Acad. Sci. USA 82:3799-3803.
Fox, R. I., et al. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome. 1986. J. Immunol. 136:477-483.
Raychaudhuri, S., et al. Tumor-specific idiotype vaccines: I. Generation and characterization of internal image tumor antigen. 1986. J. Immunol. 137:1743-1749.
Lowder, J. N., et al. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: Correlation with clinical responses. 1987. Blood 69:199-210.
Kiyotaki, M., et al. Monoclonal anti-id antibodies react with varying proportions of human B lineage cells. 1987. J. Immunol. 138:4150-4158.
Burdette, S., and Schwartz, R. S. Current concepts: Immunology. Idiotypes and idiotypic networks. 1987. New Engl. J. Med. 317:219-224.
Kipps, T. J., et al. Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. 1988. J. Exp. Med. 167:840-852.
Sugano, T., et al. Human monoclonal antibody against glycoproteins of human immunodeficiency virus. 1988. Biochem. Biopyhs. Res. Comm. 155:1105-1112.
Brown, S. L., et al. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. 1989. Blood 73:651-661.
Hay, et al. 1976 Clinical Experimental Immunology, 24:396-400 Routine Assay for the Detection of Immune Complexes of Known Immunoglbulin Class Using Solid Phase Clq. s.

Affiliated with

Also associated with

Rating

Anti-idiotype antibodies reactive with shared idiotopes expresse does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-idiotype antibodies reactive with shared idiotopes expresse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-idiotype antibodies reactive with shared idiotopes expresse will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2310308